Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence (AI) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing. The study, which was published on Monday by the journal Nature Communications, will look at whether it can be used as an early warning system for flu. The two firms are hoping to improve that figure with personalised vaccines developed using a combination of 'multi-omic' molecular data and AI.
Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence (AI) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing. Flu vaccines were around 48% effective during the 2016-2017 season, according to the US Centers for Disease Control. The two firms are hoping to improve that figure with personalised vaccines developed using a combination of 'multi-omic' molecular data and AI.